Recently was documented a positive association between anti–programmed cell death 1 cutaneous toxic effects and important outcomes, such as overall survival, in patients with advanced melanoma. In our letter to the editor we have emphasized that for proper interpretation of the given data, more appropriate statistical methods should have been used.
